Share: 
Status: 
Active

Navigating Naloxone’s use in the community: Addressing education, engagement and distribution: pharmacists: on-demand

Course description
Target Audience:

Pharmacists in community-based practice.

Universal program number: 0401-0000-16-061-H04-P
CE Broker tracking number: 20-576976

This program has been approved by the Massachusetts commissioner as an approved training program on opioid antagonists.

Activity type: Application-based

Goal:

To provide the pharmacist with updated naloxone distribution and overdose education guidance to reduce patient risks as identified by the FDA and CDC.

Description:

Community pharmacies are well positioned to help address the opioid overdose epidemic through identification of at-risk individuals, proper medication management and education of appropriate overdose risk reduction messages for patients, caregivers and other members of the community. This session will begin by describing the overdose epidemic and the vital role pharmacies play in naloxone distribution, with an emphasis on how pharmacists can educate patients and caregivers on the appropriate use of naloxone, the importance of aftercare follow-up and connection to substance use disorder treatment programs, methadone providers and/or buprenorphine prescribers. Attendees will review methods to identify patients at risk for overdose based on medication- and patient-related risk factors and create personalize messages to increase patient acceptance of recommended modalities, including the identification of resources for substance abuse treatment following naloxone rescue to mitigate risk.

Learning objectives:
  1. List key national statistics related to the opioid epidemic and how legal, regulatory, and policy change can increase naloxone access to reverse the trend.
  2. Describe naloxone’s role in attenuating death and disability from the opioid overdose epidemic and key education points for administering the drug.
  3. List stigma and myths related to opioid use disorder that can impact patient access to naloxone.
  4. Identify ways to increase patient and caregiver acceptance of naloxone and other overdose risk reduction strategies.
  5. Create a local substance abuse referral resource to enable those suffering from opioid use disorder to access treatment.
To obtain credit:

Pharmacists must participate in the entire program and complete a program evaluation at the conclusion.

CPE credits will be transferred to CPE Monitor after completion of the activity. Statements of credit are only available online through CPE Monitor.

If you have a question, visit our Frequently Asked Questions page.

All other customer service questions should be directed to DRSNCE@lf1925.com.

Accreditation:

Drug Store News is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This CPE activity is approved for pharmacists and is worth 1.0 contact hours (0.1 CEUs). The activity is available for CE credit through Dec. 14, 2019.

Faculty & disclosure

Jeffrey Bratberg, PharmD, Clinical Professor of Pharmacy Practice, and Anita Jacobson, PharmD, Clinical Associate Professor of Pharmacy Practice.

Jeffrey Bratberg, Anita Jacobson and the DSN editorial and continuing education staff do not have any actual or potential conflicts of interest in relation to this lesson.

Course summary
Credit hours: 
  • 1.00 Pharmacist
Course format: 
On-demand Webinar
Course opens: 
12/14/2016
Course expires: 
12/14/2019
Please login or register to take this course.

Payment required

You must purchase this course.
Cost:
$6.99